Vein Mapping
Dr. Farag examines your legs in standing position, marks target vessels, and screens for deeper venous disease.

Smooth, Vein-Free Legs
Your Cosmetic Sclerotherapy at a glance:
Beyond a Cosmetic Annoyance
Spider veins (telangiectasias) are tiny dilated blood vessels just beneath the skin surface, typically red, blue, or purple, that branch like a spider web across the thighs, calves, and ankles. They develop from genetics, pregnancy, hormonal shifts, prolonged standing, sun exposure, and aging. While most spider veins are cosmetic only, some patients experience burning, itching, or restless legs that point to deeper venous insufficiency. Topical creams, laser-only protocols, and supplements rarely produce the smooth, even-toned legs patients are seeking.
Cosmetic sclerotherapy is the medical gold standard for spider veins on the legs. Dr. Farag injects an FDA-approved sclerosing agent (Sotradecol or Asclera) directly into the affected vessels using a 30-gauge needle. The agent irritates the vein wall, the vessel collapses, and the body gradually reabsorbs it over 4 to 12 weeks. Most patients see 50 to 80 percent improvement after a single session, with 1 to 4 sessions spaced 4 to 6 weeks apart producing the cleanest result.
Injection-Based Vein Closure
Cosmetic sclerotherapy is a minimally invasive, in-office procedure that uses a tiny needle to deliver an FDA-approved sclerosing solution directly into spider veins and small reticular veins. The two most commonly used agents at RegalMed Clinic are sodium tetradecyl sulfate (Sotradecol) and polidocanol (Asclera). Both have decades of safety data and are first-line treatments per the American Vein and Lymphatic Society guidelines.
Once injected, the sclerosing agent damages the inner lining of the vein wall (the endothelium), triggering controlled inflammation and clotting that collapse the vessel. Over the next 4 to 12 weeks, the body reabsorbs the closed vein and rerouted blood flow returns to deeper, healthy veins. Because spider veins are non-functional vessels, removing them does not affect circulation. Compression stockings worn for 5 to 7 days after treatment improve outcomes by promoting vessel closure and preventing pigmentation.
Proven, Predictable Results
FDA-approved sclerosing agents produce 50 to 80 percent clearance per session
30-gauge needle injections, no incisions, anesthesia, or surgery
Walk in, walk out, return to most activities the same day
Treated veins close permanently; new veins from genetics or sun may appear
Schedule fall or winter to be ready for swimsuit and shorts season
Personally injected by Dr. Sherry Farag, M.D.
Compare Your Options
| Treatment | Mechanism | Best For | Sessions | Downtime | Onset | Predictability |
|---|---|---|---|---|---|---|
| Cosmetic Sclerotherapy | Sclerosing agent collapses vein wall | Leg spider and reticular veins | 1 to 4 | Minimal (compression 1 week) | 4 to 12 weeks | High |
| Surface Laser Only | Heat coagulates surface vessels | Tiny facial veins, very fine leg veins | 2 to 6 | Possible bruising and pigmentation | 4 to 8 weeks | Moderate |
| Topical Creams | Surface vasoconstriction or fading agents | Cosmetic camouflage only | Daily ongoing | None | Marginal | Low |
| Compression Stockings | External pressure improves circulation | Symptom relief, prevention | Daily ongoing | None | Symptom relief only | Low for cosmetic clearance |
Personalized Candidacy Review
Cosmetic sclerotherapy is appropriate for adults with visible spider veins or small reticular veins on the legs and ankles, healthy circulation, and realistic expectations. Dr. Farag confirms candidacy through a leg exam, vein mapping, and screening for underlying venous insufficiency.
Dr. Farag performs a venous insufficiency screen during your consultation and refers any patient with truncal varicose vein disease to a vascular surgeon for evaluation before cosmetic sclerotherapy.
Dr. Farag examines your legs in standing position, marks target vessels, and screens for deeper venous disease.
The treatment area is cleansed; no anesthesia is needed because the 30-gauge needle is essentially painless.
Dr. Farag injects FDA-approved sclerosing agent into each spider vein using magnification for precision.
Compression stockings are placed immediately to support vessel closure and reduce pigmentation risk.
You receive walking, compression, sun protection, and follow up scheduling instructions before leaving.
Honest Risk Discussion
Cosmetic sclerotherapy with FDA-approved agents has a strong safety profile when performed by an experienced physician on appropriately screened patients. Common, transient side effects include bruising at injection sites (1 to 2 weeks), mild itching or burning during injection, raised welts that resolve within hours, and brown pigmentation along treated veins (called hemosiderin staining) that typically fades over 6 to 12 months.
Less common effects include matting (small new spider veins near treated areas) in 5 to 15 percent of patients, which usually responds to additional treatment, and superficial thrombophlebitis (tender, firm cord along a treated vein) that resolves with warm compresses and NSAIDs over 1 to 3 weeks.
Rare but serious risks include allergic reaction to sclerosing agent, deep vein thrombosis (less than 1 in 1,000), skin ulceration at injection site, and visual disturbance with foam sclerotherapy. Dr. Farag reviews all risks during informed consent, screens for venous and clotting risk factors, and uses liquid sclerotherapy at conservative concentrations to minimize complication risk.
Sclerotherapy pricing depends on the volume of veins treated, the number of sessions needed, and whether one or both legs are addressed. Most patients require 1 to 4 sessions spaced 4 to 6 weeks apart for optimal cosmetic clearance.
Cosmetic sclerotherapy is not covered by insurance because it treats cosmetic concerns rather than medically symptomatic varicose veins. RegalMed Clinic accepts CareCredit and Cherry financing. Final pricing is confirmed during your consultation.
Fort Myers Vein Care
Dr. Farag personally evaluates and injects every sclerotherapy session
Vein mapping and venous insufficiency screen before any injection plan
Treatment uses Sotradecol and Asclera, never compounded or off-label substitutes
Transparent education on session counts, recurrence risk, and what sclerotherapy cannot fix
What Patients Ask Dr. Farag
Most patients describe injections as a mild stinging or burning sensation lasting a few seconds per site. The 30-gauge needle is so fine that anesthesia is not needed. Discomfort is usually less than expected.
Most patients need 1 to 4 sessions spaced 4 to 6 weeks apart for optimal clearance. Light spider veins may resolve in a single session; dense, widespread patterns benefit from a planned series.
Initial fading is visible 2 to 4 weeks after the first session. Full results appear 8 to 12 weeks after the last session, once residual brown pigmentation resolves.
Treated veins close permanently. However, genetics, sun exposure, pregnancy, and hormonal changes can produce new spider veins over time. Maintenance touch-ups every 1 to 3 years are common.
There is no true downtime. You walk immediately after treatment and resume most activities the same day. Wear compression stockings for 5 to 7 days and avoid hot baths, sauna, and direct sun for 2 weeks.
Cosmetic sclerotherapy treats spider veins and small reticular veins. Larger varicose veins typically require duplex ultrasound evaluation and may need endovenous ablation by a vascular specialist before or instead of sclerotherapy.
Florida patients often plan sessions for fall and winter so legs are clear by swimsuit season. Treated areas must avoid direct sun for 2 to 4 weeks per session.
Cosmetic sclerotherapy is generally not covered by insurance. Symptomatic varicose vein treatment may be covered when documented venous insufficiency is present, but that typically requires referral to a vascular specialist.